61 related articles for article (PubMed ID: 25411791)
1. Primary membranoproliferative glomerulonephritis in Sfax, Tunisia: epidemiologic profile and prognostic factors.
Agrebi I; Kammoun K; Dammak N; Hachicha J; Boudawara T; Jarraya F; Hmida MB
Pan Afr Med J; 2021; 38():218. PubMed ID: 34046124
[TBL] [Abstract][Full Text] [Related]
2. The effects of add-on corticosteroids on renal outcomes in patients with biopsy proven HIV associated nephropathy: a single centre study from South Africa.
Wearne N; Swanepoel CR; Duffield MS; Davidson BJ; Manning K; Tiffin N; Boulle A; Rayner BL; Naidu P; Okpechi IG
BMC Nephrol; 2019 Feb; 20(1):44. PubMed ID: 30728003
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of Histologically Proven Glomerulonephritis in Africa: A Systematic Review and Meta-Analysis.
Okpechi IG; Ameh OI; Bello AK; Ronco P; Swanepoel CR; Kengne AP
PLoS One; 2016; 11(3):e0152203. PubMed ID: 27011216
[TBL] [Abstract][Full Text] [Related]
4. Mesangiocapillary glomerulonephritis.
D'Amico G; Ferrario F
J Am Soc Nephrol; 1992 Apr; 2(10 Suppl):S159-66. PubMed ID: 1534701
[TBL] [Abstract][Full Text] [Related]
5. [Mesangiocapillary glomerulonephritis].
Pál K; Nagy J
Orv Hetil; 1996 Jun; 137(26):1403-7. PubMed ID: 9182265
[TBL] [Abstract][Full Text] [Related]
6. Outcome of patients with primary immune-complex type mesangiocapillary glomerulonephritis (MCGN) in Cape Town South Africa.
Okpechi IG; Dlamini TA; Duffield M; Rayner BL; Moturi G; Swanepoel CR
PLoS One; 2014; 9(11):e113302. PubMed ID: 25411791
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of immunoglobulin-associated mesangiocapillary glomerulonephritis: A South African experience.
Chothia MY; Panday AS; Coetzee L; Bates W
Nephrology (Carlton); 2020 Oct; 25(10):765-774. PubMed ID: 32463170
[TBL] [Abstract][Full Text] [Related]
8. Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis.
Cansick JC; Lennon R; Cummins CL; Howie AJ; McGraw ME; Saleem MA; Tizard EJ; Hulton SA; Milford DV; Taylor CM
Nephrol Dial Transplant; 2004 Nov; 19(11):2769-77. PubMed ID: 15385635
[TBL] [Abstract][Full Text] [Related]
9. Out of Africa: Complete and partial remissions as a combined outcome in patients with idiopathic membranous glomerulonephritis in Cape Town.
Ameh OI; Swanepoel CR; Aderibigbe A; Kengne AP; Okpechi IG
Nephrology (Carlton); 2016 Dec; 21(12):1010-1016. PubMed ID: 26706191
[TBL] [Abstract][Full Text] [Related]
10. Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis.
Ayodele OE; Okpechi IG; Swanepoel CR
Nephrology (Carlton); 2010 Jun; 15(4):482-90. PubMed ID: 20609103
[TBL] [Abstract][Full Text] [Related]
11. Schistosoma mansoni-induced mesangiocapillary glomerulonephritis: influence of therapy.
Martinelli R; Noblat AC; Brito E; Rocha H
Kidney Int; 1989 May; 35(5):1227-33. PubMed ID: 2504987
[TBL] [Abstract][Full Text] [Related]
12. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis.
Lv J; Ehteshami P; Sarnak MJ; Tighiouart H; Jun M; Ninomiya T; Foote C; Rodgers A; Zhang H; Wang H; Strippoli GF; Perkovic V
CMAJ; 2013 Aug; 185(11):949-57. PubMed ID: 23798459
[TBL] [Abstract][Full Text] [Related]
13. C3 glomerulonephritis associated with monoclonal gammopathy: a case series.
Zand L; Kattah A; Fervenza FC; Smith RJ; Nasr SH; Zhang Y; Vrana JA; Leung N; Cornell LD; Sethi S
Am J Kidney Dis; 2013 Sep; 62(3):506-14. PubMed ID: 23623956
[TBL] [Abstract][Full Text] [Related]
14. Long-term renal outcome and complications in South Africans with proliferative lupus nephritis.
Ayodele OE; Okpechi IG; Swanepoel CR
Int Urol Nephrol; 2013 Oct; 45(5):1289-300. PubMed ID: 23306862
[TBL] [Abstract][Full Text] [Related]
15. Primary membranoproliferative glomerulonephritis on the decline: decreased rate from the 1970s to the 2000s in Japan.
Kawamura T; Usui J; Kaseda K; Takada K; Ebihara I; Ishizu T; Iitsuka T; Sakai K; Takemura K; Kobayashi M; Koyama A; Kanemoto K; Sumazaki R; Uesugi N; Noguchi M; Nagata M; Suka M; Yamagata K
Clin Exp Nephrol; 2013 Apr; 17(2):248-54. PubMed ID: 22971963
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
